Protein

Protein and Hydration on a GLP-1: What to Aim For and Why

Two intake problems that show up together on GLP-1 therapy: less food means less protein and less fluid. What the published guidance says, in plain numbers, and what to leave to your care team.

Protein and fluid are usually discussed separately, but on a GLP-1 medication they fail for the same reason: you eat and drink less without noticing. This piece puts the two side by side, sticks to numbers that come from published guidance, and says plainly where the numbers stop and your clinician’s judgment starts.

This is general information, not medical advice. Targets for protein, fluid and medication dose depend on your kidneys, age, other conditions and the drug you take, so settle them with your prescriber or a registered dietitian.

The short version

Protein: what the advisory says

The advisory is “Nutritional priorities to support GLP-1 therapy for obesity,” written jointly by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society (Mozaffarian et al., Obesity Pillars, 2025). On protein it says:

Note the wording: “proposed,” not “proven optimal.” These are consensus ranges, not thresholds with a trial behind each digit.

What that looks like on a plate

Take a person weighing 80 kg. The 1.2 to 1.6 range works out to roughly 96 to 128 g a day. Spread over four small eating occasions, that is 24 to 32 g each: a few eggs, a cup of Greek yogurt with a scoop of whey, or a palm-sized piece of fish or chicken. When a full meal is not happening, a protein drink or a bowl of cottage cheese covers the gap.

Other pieces on this site express the same idea per kilogram of lean mass instead of total body weight. Neither framing is wrong; they are different ways of scaling the same goal. See protein targets on GLP-1 for that version and protein pacing when appetite is low for meal-by-meal tactics.

Why protein gets the attention

Weight lost on these drugs is not all fat; some is lean tissue. The advisory pairs its protein guidance with strength training at least three times a week plus at least 150 minutes of moderate aerobic activity weekly. Protein without resistance work does less for muscle than the two together, which is covered in resistance training while on GLP-1.

Who should not self-set a high target

People with chronic kidney disease, and anyone told to limit protein, should not apply these ranges. Older adults and people at risk of bone or muscle loss often need more careful, individual planning. If any of that describes you, the number comes from your team.

Hydration: less obvious, just as real

The reference intakes

The National Academies set adequate intakes for total water of 3.7 L per day for men and 2.7 L per day for women. That figure counts all beverages and the water in food. The Academies note that roughly 80 percent comes from drinks, including caffeinated ones, and roughly 20 percent from food. These are general population figures for healthy adults, not GLP-1 targets, and needs vary with heat, activity and health.

Why GLP-1 therapy changes the picture

Two things stack up. Many people report a quieter thirst signal alongside the quieter hunger signal, and smaller meals mean less water arriving from food. Then nausea, vomiting or diarrhea, especially during dose increases, can take fluid out faster than it goes in.

This is not only a comfort issue. The U.S. prescribing information for tirzepatide (Mounjaro and Zepbound) reports postmarketing cases of acute kidney injury, some needing dialysis, in people on GLP-1 receptor agonists, mostly in those with gastrointestinal reactions that led to dehydration. It tells prescribers to monitor kidney function in patients with reactions that could cause volume depletion, particularly at initiation and dose escalation, and to advise patients to avoid fluid depletion.

Practical habits

More on fluid patterns and electrolytes is in dehydration and electrolyte attention on GLP-1.

Signs to call about

Do not try to manage these at home: vomiting or diarrhea lasting more than a day, being unable to keep fluids down, very dark or very little urine, dizziness on standing, unusual weakness, or a racing heart. Severe or persistent abdominal pain is a reason for prompt medical attention.

Putting the two together

Protein shakes and yogurt help with both jobs, since they carry fluid and protein at once. Take care with heavily sweetened or very rich options if they worsen nausea. If you take several small protein-plus-fluid servings across the day, you are not adding a chore so much as reshaping the meals you were already eating.

Bring three things to your next appointment: roughly what you eat and drink on a typical day, any symptoms that limit either, and whether your kidney function has been checked recently. That gives your prescriber or dietitian enough to set a protein target and a fluid plan that fit you.

Common questions

Is 1.2 to 1.6 g/kg safe for everyone? No. It is a range proposed for active weight reduction in people without a reason to restrict protein. Kidney disease changes the answer.

Do I need to drink 3 liters a day? Not necessarily. The reference intakes cover total water from all sources for healthy adults, and food normally supplies some of it. Ask your clinician for a target if you have heart or kidney conditions.

Should I drink more when I feel sick? Small, frequent sips are usually better tolerated. If you cannot keep fluids down, contact your care team.

Sources

  1. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity Pillars. 2025;15:100181. Full text
  2. National Academies of Sciences, Engineering, and Medicine. Dietary Reference Intakes for water, potassium, sodium, chloride, and sulfate (2004 report summary).
  3. Eli Lilly. Mounjaro prescribing information, sections on acute kidney injury and gastrointestinal adverse reactions (FDA-hosted).
Medically reviewed by Jonathan Park, MD, FACE on .